Pavesio Alessandra 4
4 · Bioventus Inc. · Filed Feb 15, 2022
Insider Transaction Report
Form 4
Pavesio Alessandra
SVP & Chief Science Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2022-02-11+1,470→ 120,263 total - Exercise/Conversion
Restricted Stock Units
2022-02-11−1,470→ 0 total→ Class A Common Stock (1,470 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The restricted stock units vested on February 11, 2022.